📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated. (2014)

First Author: Dos Santos RG

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/ftd.0000000000000028

PubMed Identifier: 24413570

Publication URI: http://europepmc.org/abstract/MED/24413570

Type: Journal Article/Review

Volume: 36

Parent Publication: Therapeutic drug monitoring

Issue: 1

ISSN: 0163-4356